Comprehensive Stock Analysis of Vanda Pharmaceuticals Inc.(NASDAQ:VNDA): Bio-Path Holdings, Inc.(NASDAQ:BPTH)

0
2

Vanda Pharmaceuticals Inc. (VNDA) will report its next earnings on Nov 06 AMC. The company reported the earnings of $1.84/Share in the last quarter where the estimated EPS by analysts was $0.07/share. The difference between the expected and actual EPS was $1.77/share, which represents an Earnings surprise of 2528.6%.

Many analysts are providing their Estimated Earnings analysis for Vanda Pharmaceuticals Inc. and for the current quarter 4 analysts have projected that the stock could give an Average Earnings estimate of $0.05/share. These analysts have also projected a Low Estimate of $0.01/share and a High Estimate of $0.15/share.

In case of Revenue Estimates, 4 analysts have provided their consensus Average Revenue Estimates for Vanda Pharmaceuticals Inc. as 59.65 Million. According to these analysts, the Low Revenue Estimate for Vanda Pharmaceuticals Inc. is 56.9 Million and the High Revenue Estimate is 62 Million. The company had Year Ago Sales of 53.04 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for VNDA to be -65%. They are projecting Next Quarter growth of -92.31%. For the next 5 years, Vanda Pharmaceuticals Inc. is expecting Growth of 225% per annum, whereas in the past 5 years the growth was -60.53% per annum.

Some buy side analysts are also providing their Analysis on Vanda Pharmaceuticals Inc., where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 2 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Vanda Pharmaceuticals Inc. might touch $52 high while the Average Price Target and Low price Target is $28.2 and $17 respectively.

Vanda Pharmaceuticals Inc. closed its last trading session at $13.14 with the gain of 10.58%. The Market Capitalization of the company stands at 752.8 Million. The Company has 52-week high of $33.44 and 52-week low of $11.83. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 7.28% where SMA50 and SMA200 are 7.22% and -9.58% respectively. The Company Touched its 52-Week High on 12/03/18 and 52-Week Low on 07/25/19.

The Relative Volume of the company is 2.02 and Average Volume (3 months) is 596.21 million. The company’s P/E (price to earnings) ratio is 28.05 and Forward P/E ratio of 26.76.

The company shows its Return on Assets (ROA) value of 8.3%. The Return on Equity (ROE) value stands at 10.2%. While it’s Return on Investment (ROI) value is 7.8%.

While looking at the Stock’s Performance, Vanda Pharmaceuticals Inc. currently shows a Weekly Performance of 7.55%, where Monthly Performance is 17.37%, Quarterly performance is -1.09%, 6 Months performance is -10.75% and yearly performance percentage is -27.75%. Year to Date performance value (YTD perf) value is -44.39%. The Stock currently has a Weekly Volatility of 4.34% and Monthly Volatility of 3.31%.

Bio-Path Holdings, Inc. (BPTH) will report its next earnings on Nov 14 BMO. The company reported the earnings of $-0.87/Share in the last quarter where the estimated EPS by analysts was $-0.6/share. The difference between the expected and actual EPS was $-0.27/share, which represents an Earnings surprise of -45%.

Many analysts are providing their Estimated Earnings analysis for Bio-Path Holdings, Inc. and for the current quarter 1 analysts have projected that the stock could give an Average Earnings estimate of $-0.74/share. These analysts have also projected a Low Estimate of $-0.74/share and a High Estimate of $-0.74/share.

Some buy side analysts are also providing their Analysis on Bio-Path Holdings, Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Bio-Path Holdings, Inc. might touch $28 high while the Average Price Target and Low price Target is $28 and $28 respectively.

Bio-Path Holdings, Inc. closed its last trading session at $11.21 with the loss of -3.21%. The Market Capitalization of the company stands at 29.84 Million. The Company has 52-week high of $73.52 and 52-week low of $1.61. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -3.57% where SMA50 and SMA200 are -0.32% and -16.29% respectively. The Company Touched its 52-Week High on 03/07/19 and 52-Week Low on 01/22/19.

The Relative Volume of the company is 1.09 and Average Volume (3 months) is 63.3 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -76%. The Return on Equity (ROE) value stands at -84.8%. While it’s Return on Investment (ROI) value is 0%.

While looking at the Stock’s Performance, Bio-Path Holdings, Inc. currently shows a Weekly Performance of 0.37%, where Monthly Performance is 21.77%, Quarterly performance is -10.77%, 6 Months performance is -32.06% and yearly performance percentage is 13.61%. Year to Date performance value (YTD perf) value is 210%. The Stock currently has a Weekly Volatility of 5.14% and Monthly Volatility of 7.22%.

SHARE